Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社, Chūgai Seiyaku kabushiki gaisha) is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.
|Chūgai Seiyaku kabushiki gaisha|
|Industry||Pharmaceutical Industry, Business import, production and development of drugs for medical sales|
|Founded||March 8, 1943|
|Headquarters||Nihonbashi Mitsui Tower, Nihonbashi Muromachi 2-1-1, Chūō, Tokyo|
On the registration Headquarter: Tokyo Kita (Tokyo)
|Osamu Nagayama - Chairman and Tatsuro Kosaka - CEO|
|Revenue||72.9 billion capital of 47 million yen. Standalone sales of 329.2 billion yen and 344.8 billion yen consolidated |
|Parent||Hoffmann-La Roche (61.62%)|
This is a timeline of important events of Chugai Pharmaceutical.
|Wikimedia Commons has media related to Chugai Pharmaceutical.|